[Therapy and prophylaxis of recurrent erysipelas (author's transl)].
17 patients suffering from chronically recurrent erysipelas were treated through 10 days - every day - with 10 mega Na-penicillin G intravenously, before noon, and with 1.2 mega (900000 units clemizole penicillin G plus 300000 units Na-penicillin G) intramuscularly or 1 to 2 mega penicillin V acid orally, in the afternoon. Thereafter, these patients were to be injected through six months, in two week intervals, a repository penicillin (600000 units benzathine penicillin G, 300000 unmand in a divers manner. During the observation period from 1 7/12 to 2 8/12 years, 11 out of 17 patients remained without relapse. Frequency of recidivation significantly decreased in 3 patients; no improvement was achieved in the three last patients.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D004359:Drug Therapy, Combination; D004886:Erysipelas / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans; D007275:Injections, Intravenous; D008134:Long-Term Care; D008875:Middle Aged; D010400:Penicillin G / Q000627:therapeutic use; D010401:Penicillin G Benzathine / Q000627:therapeutic use; D010404:Penicillin V / Q000627:therapeutic use; D010406:Penicillins / Q000627:therapeutic use*; D012008:Recurrence
D010406:Penicillins; D010400:Penicillin G; D010401:Penicillin G Benzathine; D010404:Penicillin V
Zur Therapie und Prophylaxe des rezidivierenden Erysipels